Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Incidence and Severity of Drug Interactions Before and After Switching Antiretroviral Therapy to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Treatment Experienced Patients

NCT03789968 is registered in ClinicalTrials.gov with Thomas Jefferson University as lead sponsor.

NCT NCT03789968
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03789968 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Incidence and Severity of Drug Interactions Before and After Switching Antiretroviral Therapy to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Treatment Experienced Patients
Lead sponsor
Thomas Jefferson University
Phase
Observational
Overall status
Completed
Start date
September 1, 2019
Completion date
October 5, 2020
Enrollment
411 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv/aids